Avandia Health Risks
| Avandia is the drug that is used to treat “adult-onset” or “type-2” diabetes. Type 2 diabetes is a a serious life threatening disease for eighteen to twenty million Americans. |
|
Diabetes is the cause of blindness, coronary heart disease, kidney failure, and even limb amputation.
U.S. Food and Drug Administration (FDA) released a safety warning on Avandia on May 21, 2007. Avandia has adverse health effects, especially for the heart such as edema, fluid retention, and congestive heart failure. FDA has updated Avandia labeling to reflect the new data and risk of Avandia. Nevertheless, FDA advisory committee still allow Avandia on the market.
The Patients who are taking Avandia are advice to talk to the healthcare professional, especially if you have a history of heart disease.
The drug manufacture has legal responsibility to make the drug as safe as possible. If they fail to provide adequate warnings about the nature of the drugs, , they will be responsible for pharmaceutical liability case.
FDA Issues Safety Alert on Avandia :
" The U.S. Food and Drug Administration (FDA) is aware of a potential safety issue related to Avandia (rosiglitazone), a drug approved to treat type 2 diabetes. Safety data from controlled clinical trials have shown that there is a potentially significant increase in the risk of heart attack and heart-related deaths in patients taking Avandia. However, other published and unpublished data from long-term clinical trials of Avandia, including an interim analysis of data from the RECORD trial (a large, ongoing, randomized open label trial) and unpublished reanalyses of data from DREAM (a previously conducted placebo-controlled, randomized trial) provide contradictory evidence about the risks in patients treated with Avandia."
A - Z Dangerous Products :
|
